IMPACT OF ALPHA-ADRENERGIC CORONARY VASOCONSTRICTION ON THE TRANSMURAL MYOCARDIAL BLOOD-FLOW DISTRIBUTION DURING HUMORAL AND NEURONAL ADRENERGIC ACTIVATION
D. Baumgart et al., IMPACT OF ALPHA-ADRENERGIC CORONARY VASOCONSTRICTION ON THE TRANSMURAL MYOCARDIAL BLOOD-FLOW DISTRIBUTION DURING HUMORAL AND NEURONAL ADRENERGIC ACTIVATION, Circulation research, 73(5), 1993, pp. 869-886
Increased heart rate and left ventricular pressure during humoral and
neuronal adrenergic activation act to restrict blood flow preferential
ly in the subendocardium. The hypothesis was advanced that alpha-adren
ergic coronary vasoconstriction preferentially in the subepicardium ma
y counterbalance the enhanced extravascular compression in the subendo
cardium and serve to maintain blood flow transmurally uniform. In 40 a
nesthetized dogs, regional myocardial blood flow was determined with c
olored microspheres; wall function, with sonomicrometry. Humoral adren
ergic activation (HAA) was induced by a combination of intravenous atr
opine, intravenous norepinephrine, and atrial pacing during baseline c
oronary vasomotor tone (group 1, n = 6) and in the presence of maximal
coronary vasodilation with intravenous dipyridamole (group 2, n = 6).
In an additional group, HAA was induced by intravenous norepinephrine
in the presence of dipyridamole but without atropine and atrial pacin
g in order to increase end-diastolic left ventricular pressure (group
3, n = 6). Measurements were performed at rest, during HAA, and during
ongoing HAA with the intracoronary infusion of the alpha-antagonist p
hentolamine (Phen). At unchanged mean aortic pressure, Phen improved b
lood flow particularly to the inner layers as follows: from 1.42 +/- 0
.40 (mean +/- SD) to 1.90 +/- 0.40 mL/(min.g) (group 1, P < .05), from
4.99 +/- 2.31 to 5.53 +/- 2.56 mL/(min.g) (group 2, P < .05), and fro
m 6.01 +/- 1.41 to 6.29 +/- 1.27 mL/(min.g) (group 3, P < .05), associ
ated with a decrease in outer layer blood flow in groups 2 and 3. In 1
6 additional dogs, beta-adrenoceptors were blocked by propranolol and
muscarinic receptors by atropine. Neuronal adrenergic activation (NAA)
was induced by cardiac sympathetic nerve stimulation (CSNS) during ba
seline coronary vasomotor tone (group 4, n = 8) and in the presence of
maximal vasodilation (group 5, n = 8). Measurements were performed at
rest, during a first CSNS, and 20 minutes later during a second CSNS
+ Phen. The reproducibility of two consecutive episodes of CSNS 20 min
utes apart was demonstrated in a separate set of experiments (n = 6).
At matched mean aortic pressures, Phen improved blood flow to all myoc
ardial layers in group 4, whereas in group 5, Phen induced a redistrib
ution of myocardial blood flow toward subepicardial layers [from 4.44
+/- 0.96 to 4.81 +/- 0.83 mL/(min.g), P < .05] at the expense of inner
layers. With the addition of Phen, there was no change in regional wa
ll function in any group of dogs studied. Thus, during HAA, alpha-adre
nergic coronary vasoconstriction does not exert a beneficial effect on
transmural blood flow distribution. During NAA, a beneficial effect o
f a-adrenergic coronary vasoconstriction becomes apparent only under c
onditions of maximal coronary vasodilation.